Literature DB >> 1716876

The structure of human acidic fibroblast growth factor and its interaction with heparin.

R A Copeland1, H Ji, A J Halfpenny, R W Williams, K C Thompson, W K Herber, K A Thomas, M W Bruner, J A Ryan, D Marquis-Omer.   

Abstract

The secondary and tertiary structure of recombinant human acidic fibroblast growth factor (aFGF) has been characterized by a variety of spectroscopic methods. Native aFGF consists of ca. 55% beta-sheet, 20% turn, 10% alpha-helix, and 15% disordered polypeptide as determined by laser Raman, circular dichroism, and Fourier transform infrared spectroscopy; the experimentally determined secondary structure content is in agreement with that calculated by the semi-empirical methods of Chou and Fasman (Chou, P. Y., and Fasman, G. C., 1974, Biochemistry 13, 222-244) and Garnier et al. (Garnier, J. O., et al., 1978, J. Mol. Biol. 120, 97-120). Using the Garnier et al. algorithm, the major secondary structure components of aFGF have been assigned to specific regions of the polypeptide chain. The fluorescence spectrum of native aFGF is unusual in that it is dominated by tyrosine fluorescence despite the presence of a tryptophan residue in the protein. However, tryptophan fluorescence is resolved upon excitation above 295 nm. The degree of tyrosine and tryptophan solvent exposure has been assessed by a combination of ultraviolet absorption, laser Raman, and fluorescence spectroscopy; the results suggest that seven of the eight tyrosine residues are solvent exposed while the single tryptophan is partially inaccessible to solvent in native aFGF, consistent with recent crystallographic data. Denaturation of aFGF by extremes of temperature or pH leads to spectroscopically distinct conformational states in which contributions of tyrosine and tryptophan to the fluorescence spectrum of the protein vary. The protein is unstable at physiological temperatures. Addition of heparin or other sulfated polysaccharides does not affect the spectroscopic characteristics of native aFGF. These polymers do, however, dramatically stabilize the native protein against thermal and acid denaturation as determined by differential scanning calorimetry, circular dichroism, and fluorescence spectroscopy. The interaction of aFGF with such polyanions may play a role in controlling the activity of this growth factor in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716876     DOI: 10.1016/0003-9861(91)90441-k

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  23 in total

1.  Accommodation of a highly symmetric core within a symmetric protein superfold.

Authors:  Stephen R Brych; Jaewon Kim; Timothy M Logan; Michael Blaber
Journal:  Protein Sci       Date:  2003-12       Impact factor: 6.725

2.  An empirical phase diagram approach to investigate conformational stability of "second-generation" functional mutants of acidic fibroblast growth factor-1.

Authors:  Mohammad A Alsenaidy; Tingting Wang; Jae Hyun Kim; Sangeeta B Joshi; Jihun Lee; Michael Blaber; David B Volkin; C Russell Middaugh
Journal:  Protein Sci       Date:  2012-02-06       Impact factor: 6.725

3.  Experimental support for the evolution of symmetric protein architecture from a simple peptide motif.

Authors:  Jihun Lee; Michael Blaber
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

4.  Instability restricts signaling of multiple fibroblast growth factors.

Authors:  Marcela Buchtova; Radka Chaloupkova; Malgorzata Zakrzewska; Iva Vesela; Petra Cela; Jana Barathova; Iva Gudernova; Renata Zajickova; Lukas Trantirek; Jorge Martin; Michal Kostas; Jacek Otlewski; Jiri Damborsky; Alois Kozubik; Antoni Wiedlocha; Pavel Krejci
Journal:  Cell Mol Life Sci       Date:  2015-02-18       Impact factor: 9.261

5.  An S116R Phosphorylation Site Mutation in Human Fibroblast Growth Factor-1 Differentially Affects Mitogenic and Glucose-Lowering Activities.

Authors:  Xue Xia; Ozan S Kumru; Sachiko I Blaber; C Russell Middaugh; Ling Li; David M Ornitz; Jae Myoung Suh; Annette R Atkins; Michael Downes; Ronald M Evans; Connie A Tenorio; Ewa Bienkiewicz; Michael Blaber
Journal:  J Pharm Sci       Date:  2016-10-20       Impact factor: 3.534

6.  Release of FGF1 and p40 synaptotagmin 1 correlates with their membrane destabilizing ability.

Authors:  Irene Graziani; Cinzia Bagalá; Maria Duarte; Raffaella Soldi; Vihren Kolev; Francesca Tarantini; Thallapuranam Krishnaswamy Suresh Kumar; Andrew Doyle; David Neivandt; Chin Yu; Thomas Maciag; Igor Prudovsky
Journal:  Biochem Biophys Res Commun       Date:  2006-08-14       Impact factor: 3.575

7.  Formulation design of acidic fibroblast growth factor.

Authors:  P K Tsai; D B Volkin; J M Dabora; K C Thompson; M W Bruner; J O Gress; B Matuszewska; M Keogan; J V Bondi; C R Middaugh
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

8.  The effects of excipients on protein aggregation during agitation: an interfacial shear rheology study.

Authors:  Lu Liu; Wei Qi; Daniel K Schwartz; Theodore W Randolph; John F Carpenter
Journal:  J Pharm Sci       Date:  2013-05-27       Impact factor: 3.534

9.  Ca2+-induced linker transformation leads to a compact and rigid collagen-binding domain of Clostridium histolyticum collagenase.

Authors:  Sagaya T L Philominathan; Osamu Matsushita; Robert Gensure; Joshua Sakon
Journal:  FEBS J       Date:  2009-05-28       Impact factor: 5.542

10.  Mitogenic activity of acidic fibroblast growth factor is enhanced by highly sulfated oligosaccharides derived from heparin and heparan sulfate.

Authors:  A G Gambarini; C A Miyamoto; G A Lima; H B Nader; C P Dietrich
Journal:  Mol Cell Biochem       Date:  1993-07-21       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.